NCS Multistage director granted 3,221 shares

NCS Multistage Holdings director John D. Deane received an award of 3,221 shares of common stock on March 3, 2026 through a grant or similar acquisition at no stated price.

Rhea-AI Filing Summary

NCS Multistage Holdings director John D. Deane received an award of 3,221 shares of common stock on March 3, 2026 through a grant or similar acquisition at no stated price. Following this award, his directly held common stock totaled 32,771 shares, including 3,221 restricted stock units that vest and settle on February 28, 2027.

The filing also reports 10,731 shares of common stock held indirectly by the Deane Family Partnership Limited, a limited partnership for which Deane is the sole general partner. He disclaims beneficial ownership of these indirectly held securities except to the extent of his pecuniary interest in them.

Insider Trade Summary

Grant/Award: 3,221 shares

Grant/Award 2 txns

Insider DEANE JOHN D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,221	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 32,771 shares (Direct); Common Stock — 10,731 shares (Indirect, By Family Partners Limited)

Footnotes (2)

1. F1. Includes 3,221 restricted stock units which vest and settle on February 28, 2027.
2. F2. These securities are held by the Deane Family Partnership Limited, a limited partnership of which the Reporting Person is the sole general partner. The Reporting Person disclaims beneficial ownership of the Issuer's securities held by the Deane Family Partnership Limited except to the extent of his pecuniary interest therein.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NCSM director John D. Deane report?

John D. Deane reported acquiring 3,221 shares of NCS Multistage common stock on March 3, 2026 through a grant or similar award. This increased his directly held position and included restricted stock units subject to future vesting conditions.

How many NCSM shares does John D. Deane hold directly after the grant?

After the March 3, 2026 grant, John D. Deane directly held 32,771 shares of NCS Multistage common stock. This total includes 3,221 restricted stock units scheduled to vest and settle on February 28, 2027, reflecting both current and time-based equity interests.

When do John D. Deane’s NCSM restricted stock units vest?

The 3,221 restricted stock units reported by John D. Deane vest and settle on February 28, 2027. Until that vesting date, the units remain subject to applicable grant conditions, after which they are scheduled to convert into common stock.

What indirect NCSM holdings are associated with John D. Deane?

The filing reports 10,731 NCS Multistage shares held indirectly through the Deane Family Partnership Limited. John D. Deane is the sole general partner of this partnership and disclaims beneficial ownership of these securities except for his pecuniary interest.

Did John D. Deane buy or sell NCSM shares on the open market?

The reported 3,221-share transaction is classified as a grant, award, or other acquisition at a price of $0.00 per share, not an open-market trade. There are no reported open-market purchases or sales in this specific Form 4 filing.

How is beneficial ownership of NCSM shares described for Deane’s partnership holdings?

Shares held by the Deane Family Partnership Limited are attributed to that entity, with John D. Deane disclaiming beneficial ownership except for his pecuniary interest. This language clarifies that his economic interest is limited to his share in the partnership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 05:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEANE JOHN D

(Last) (First) (Middle)

C/O NCS MULTISTAGE HOLDINGS, INC.

19350 STATE HIGHWAY 249, SUITE 600

(Street)

HOUSTON TX 77070

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NCS Multistage Holdings, Inc. [ NCSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		3,221	A	$0	32,771(1)	D
Common Stock								10,731	I	By Family Partners Limited(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 3,221 restricted stock units which vest and settle on February 28, 2027.

2. These securities are held by the Deane Family Partnership Limited, a limited partnership of which the Reporting Person is the sole general partner. The Reporting Person disclaims beneficial ownership of the Issuer's securities held by the Deane Family Partnership Limited except to the extent of his pecuniary interest therein.

	/s/ Ori Lev, attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.